EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 23rd, 2023 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 23rd, 2023 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of November 8, 2022, by and between Wave Life Sciences USA, Inc., a Delaware corporation (“Company”) and a wholly owned subsidiary of Wave Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Chris Francis (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 4th, 2021 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 4th, 2021 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of January 1, 2021, by and between Wave Life Sciences USA, Inc., a Delaware corporation (“Company”) and a wholly owned subsidiary of Wave Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Kyle Moran (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 10th, 2020 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of May 8, 2020, by and between Wave Life Sciences USA, Inc., a Delaware corporation (“Company”) and a wholly owned subsidiary of Wave Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Chandra Vargeese (“Executive”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 10th, 2020 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledAugust 10th, 2020 Company Industry JurisdictionThis Amended and Restated Employment Agreement (the “Agreement”), made and entered into as of May 8, 2020, by and between Wave Life Sciences USA, Inc., a Delaware corporation (“Company”) and a wholly owned subsidiary of Wave Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Paul Bolno (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 5th, 2019 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 5th, 2019 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of June 28, 2019 (the “Effective Date”), by and between Wave Life Sciences USA, Inc., a Delaware corporation (“Company”) and a wholly owned subsidiary of Wave Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Mark Baldry (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of August 16, 2016 (the “Effective Date”), by and between WAVE Life Sciences USA, Inc., a Delaware corporation (the “Company”) and a wholly owned subsidiary of WAVE Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Keith C. Regnante. (“Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Wave Life Sciences Ltd. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Employment Agreement (the “Agreement”), made and entered into as of July 11, 2016 (the “Effective Date”), by and between WAVE Life Sciences USA, Inc., a Delaware corporation (the “Company”) and a wholly owned subsidiary of WAVE Life Sciences Ltd., a Singapore corporation (the “Parent Company”), and Michael Panzara, M.D. (“Executive”).